The pathophysiology and treatment of glaucoma: a review

RN Weinreb, T Aung, FA Medeiros - Jama, 2014 - jamanetwork.com
Importance Glaucoma is a worldwide leading cause of irreversible vision loss. Because it
may be asymptomatic until a relatively late stage, diagnosis is frequently delayed. A general …

Ocular perfusion pressure in glaucoma

VP Costa, A Harris, D Anderson… - Acta …, 2014 - Wiley Online Library
This review article discusses the relationship between ocular perfusion pressure and
glaucoma, including its definition, factors that influence its calculation and epidemiological …

Glaucoma treatment device

E de Juan Jr, S Boyd, ME Deem, HS Gifford III… - US Patent …, 2014 - Google Patents
Methods and devices are adapted for implanting into the eye. An incision is formed in the
cornea of the eye and a shunt is inserted through the incision into the anterior chamber of …

[HTML][HTML] Rates of glaucomatous visual field change in a large clinical population

BC Chauhan, R Malik, LM Shuba… - … & visual science, 2014 - tvst.arvojournals.org
Methods.: Mean deviation (MD) rate was computed in one randomly selected eye of all
glaucoma patients and suspects with≥ 5 examinations in a tertiary eye-care center …

Nocturnal systemic hypotension increases the risk of glaucoma progression

ME Charlson, CG de Moraes, A Link, MT Wells… - Ophthalmology, 2014 - Elsevier
Objective The objective of this prospective, longitudinal study of patients with normal-tension
glaucoma (NTG) was to determine whether patients with nocturnal hypotension are at …

Ocular implant with hydrogel expansion capabilities

T Silvestrini, E de Juan Jr, D Rosenman - US Patent 8,672,870, 2014 - Google Patents
An ocular implant includes an elongate member having an internal lumen forming a flow
pathway that provides a fluid pathway between the anterior chamber and the suprachoroidal …

Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice

G Holló, F Topouzis, RD Fechtner - Expert Opinion on …, 2014 - Taylor & Francis
Introduction: Several large, randomized, prospective clinical trials have demonstrated that
medical therapy to reduce intraocular pressure (IOP) delays the onset and decreases …

Benzalkonium chloride and glaucoma

CA Rasmussen, PL Kaufman… - Journal of Ocular …, 2014 - liebertpub.com
Glaucoma patients routinely take multiple medications, with multiple daily doses, for years or
even decades. Benzalkonium chloride (BAK) is the most common preservative in glaucoma …

Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion (s)

GJ Tearney, BE Bouma, D Yelin - US Patent 8,838,213, 2014 - Google Patents
Exemplary apparatus and process can be provided for imaging information associated with
at least one portion of a sample. For example,(i) at least two first different wavelengths of at …

Glaucoma management: relative value and place in therapy of available drug treatments

D Sambhara, AA Aref - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Lowering intraocular pressure (IOP) is the only proven therapeutic intervention for
glaucomatous optic neuropathy. Despite advances in laser and microsurgical techniques …